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ORIGINAL ARTICLE
Short-term effects of repetitive transcranial magnetic
stimulation on sleep bruxism – a pilot study
Wei-Na Zhou1, Hai-Yang Fu2, Yi-Fei Du3, Jian-Hua Sun2, Jing-Lu Zhang1, Chen Wang1, Peter Svensson4 and
Ke-Lun Wang1,5
The purpose of this study was to investigate the effects of repetitive transcranial magnetic stimulation (rTMS) on patients with
sleep bruxism (SB). Twelve patients with SB were included in an open, single-intervention pilot study. rTMS at 1 Hz and an intensity of
80% of the active motor threshold was applied to the ‘hot spot’ of the masseter muscle representation at the primary motor cortex
bilaterally for 20min per side each day for 5 consecutive days. The jaw-closing muscle electromyographic (EMG) activity during sleep
was recorded with a portable EMG recorder at baseline, during rTMS treatment and at follow-up for 5 days. In addition, patients
scored their jaw-closing muscle soreness on a 0–10 numerical rating scale (NRS). Data were analysed with analysis of variance. The
intensity of the EMG activity was suppressed during and after rTMS compared to the baseline (P 5 0.04; P 5 0.02, respectively).
The NRS score of soreness decreased significantly during and after rTMS compared with baseline (P, 0.01). These findings indicated
a significant inhibition of jaw-closing muscle activity during sleep along with a decrease of muscle soreness. This pilot study raises
the possibility of therapeutic benefits from rTMS in patients with bruxism and calls for further and more controlled studies.
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INTRODUCTION
Sleep bruxism (SB) is defined as a repetitive jaw-closing muscle activ-
ity characterised by clenching or grinding the teeth and/or by bracing
or thrusting themandible during sleep.1 SB is thought to be potentially
harmful to the stomatognathic system because it causes, for example,
excessive tooth wear, masseter hypertrophy, temporomandibular dis-
orders (TMD) and headaches.2–4 The aetiology of SB is complex but
most likely includes arousal responses and autonomic dysregulation,
genetic, psycho-emotional and pharmacological risk factors.5
In recent years, the central nervous system factors have been empha-
sised over the peripheral factors, such as occlusal discrepancies and
deviations, in bony structures of the orofacial region.5–6 SB may be
considered an extreme manifestation of the masticatory muscle acti-
vity that occurs during sleep in most individuals.6–7 Interestingly, a
neuroimaging study suggested an association between bruxism and a
dysfunction in the central regulation of jaw movements. The onset of
rhythmic masticatory muscle activity (RMMA) and SB episodes was
suggested to be influenced by brief and transient arousal responses in
the brainstem activity according to a polysomnographic (PSG) study.8
A magnetoencephalography study indicated that SB patients had sig-
nificantly larger event-related desynchronisation in the sensory-motor
area than did non-bruxism subjects.9 A sequential change from auto-
nomic (cardiac) and cortical activities preceded SB-related jaw motor
activity, and repetitive stimulation to the primary face motor cortex
was shown to induce rhythmic jawmovements in non-human primate
studies.10 Accordingly, SB patients might exhibit a dysfunction of
motor-related subcortical and cortical networks.
Traditional treatment strategies of SB include occlusal, beha-
vioural, physical and pharmacological approaches.11 However, no
permanent suppression of jaw-closing muscle activity has yet been
demonstrated, and reversible and non-invasive approaches are there-
fore preferred.2,11–12
Transcranial magnetic stimulation (TMS) has been widely used in
humans to assess the motor cortex connection to a number of target
muscles,13–14 and in recent years, repetitive applications of TMS
(rTMS) have been used to study the inhibitory or excitatory influence
on a variety of cortical functions. Low-frequency (1 Hz) rTMS has
been found to inhibit neuronal firing in a localised cortical area,
whereas high-frequency rTMS inversely led to neuronal depolarisa-
tion under the stimulating coil. rTMS has now been clinically applied
for management of depression, pain and tinnitus,14–15 but to date, no
study has examined its effect on SB. Based on the reviewed literature, it
1Jiangsu Key Laboratory of Oral Diseases, Orofacial Pain and Temporo-mandibular Disorders Research Unit, Institute of Stomatology, Affiliated Hospital of Stomatology, Nanjing
Medical University, Nanjing, China; 2Department of Rehabilitation, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing, China; 3Department of Oral
and Maxillofacial Surgery, Affiliated Hospital of Stomatology, Nanjing Medical University, Nanjing, China; 4Section of Clinical Oral Physiology, School of Dentistry, Aarhus
University, Aarhus, Denmark and 5Center for Sensory-Motor Interaction (SMI), Aalborg University, Aalborg, Denmark
Correspondence: Dr JL Zhang, Jiangsu Key Laboratory of Oral Diseases, Orofacial Pain and temporo-mandibular Disorders Research Unit, Institute of Stomatology, Affiliated
Hospital of Stomatology, Nanjing Medical University, 136 Hanzhong Road, Nanjing 210029, China
E-mail: zhjllym@njmu.edu.cn
Accepted 31 August 2015
OPEN
International Journal of Oral Science (2016)     8,
www.nature.com/ijos
61–65
(2016) 8, –65; doi:10.1038/ijos.2015.35; published online 13 November 201561
seems plausible that rTMS of the primary sensory-motor cortex rep-
resentation of the jaw-closing muscle could have a beneficial effect
on SB.
In the present pilot study, we attempted to use rTMS to suppress the
corticobulbar pathways and inhibit the jaw-closing muscle activity
during sleep. Potential clinical effects were examined by assessing
self-reported masseter muscle soreness. An open, single-intervention
trial design was applied to provide preliminary evidence of treatment
effects before the initiation of a randomised clinical trial. Thus, the
purpose of this study was to investigate the possible effects of rTMS
on SB.
MATERIALS AND METHODS
Ethics
The study was approved by the Human Research Ethics Committee at
Nanjing Medical University. All patients completed a modified ver-
sion of the rTMS Adult Safety Screen Questionnaire to ensure that
there was no contraindication for rTMS.
Patients
All participants were selected from patients referred to the TMD
Clinic, Stomatology Hospital of Jiangsu province, China. Sixty
patients with probable SB were initially evaluated, and 18 patients
were eligible and agreed to participate in the experiment. After one
week, six patients withdrew from the study for personal reasons. A
total of 12 individuals (7 men and 5 women, age: (27 6 5.4) years)
completed the study.
The same dentist administered the questionnaire and performed the
clinical assessment on all patients in accordance with a diagnosis of
‘probable’ SB.1 The patients were aware of their tooth-grinding activ-
ity during sleep or had been told of it by a bed partner. Furthermore,
there were positive findings for one or more of the followings signs or
symptoms: (i) tooth wear and/or shiny spots on dental restorations;
(ii) frequent reports of stiffness, fatigue or discomfort in the jaw-
closing muscles upon awakening; and (iii) masseter muscle hyper-
trophy during voluntary contractions.16
The exclusion criteria were a history of neurologic or psychiatric
disorders; the use of prescription medicine or drugs with possible
sleep effects or alterations of motor behaviour; an electrode gel
allergy; currently being under medical or dental treatment; having
a pacemaker or implanted defibrillator; the loss of more than two
posterior teeth except third molars; or having removable partial or
full dentures.
Study design
A pilot study with an open, single-intervention design with three
phases of investigation was chosen. In phase 1, all participants used
a portable, single-channel electromyographic (EMG) recorder in their
own home to record baseline jaw-closing muscle EMG activity during
sleep for five nights. In phase 2, all participants received rTMS treat-
ment during the day for at least five consecutive days, and the jaw-
closing muscle EMG activity was recorded during sleep on the nights
following treatment. In phase 3, all participants were followed-up with
immediately after the last day of rTMS treatment and again used the
portable EMG recorder for at least five nights.
At the end of each phase, all participants were asked to evaluate the
level of soreness in the jaw-closing muscles by choosing a score on a
numerical rating scale (NRS), where 0 represented no soreness and 10
represented the most imaginable soreness.
EMG recordings
A single-channel portable EMG device (Grindcare3; Medotech A/S,
Herlev, Denmark) was used to record EMG activity during sleep. All
recordings were performed in the subjects’ homes. The device has a
single electrode assembly with three electrode contacts. The electrodes
are designed to be placed over the anterior temporalis muscle, which is
one of the jaw-closingmuscles andmay provide the same type of EMG
information as obtained from the masseter muscle during sleep. The
EMG activity was recorded through the amplifiers (3800 times) and
filters (250–610 Hz) in the device and further analysed for events of
EMG activity using a Signal Recognition Algorithm described by
Jadidi et al.17 To determine the individual parameters, the following
set-up procedure was performed every night: patients were asked to
relax their jaw-closing muscle for 10 s. Then, they clenched their teeth
at maximal voluntary clenching (MVC) for 10 s, and 60% ofMVCwas
pre-set for the threshold of starting the EMG recording. These proce-
dures were carefully demonstrated to each participant by the exam-
iners. The device was applied before sleep and removed when the
patient woke up every day for 5 days. The number of EMG events
per hour, the intensity of the EMG (area under EMG curve) and the
total recording hours were registered.
rTMS application
Participants were tested at the same time in the afternoon (4–5 pm)
each day during the 5 consecutive days of phase 2. TMS was always
performed by the same examiner, who has extensive clinical experi-
ence with the TMS technique.
The participants were positioned comfortably on a physiotherapy
couch in a soundproof room, and TMS was performed using a
Magstim 200 stimulator (Magstim, Wales, UK) and a focal figure-8
stimulating coil (outer coil diameter 90 mm). Magnetic stimuli were
given at the optimum site (hot spot) for elicitingmotor-evoked poten-
tials (MEPs) with maximal amplitudes in the masseter muscle at the
lowest output. The optimal site was approximately 10 cm lateral to the
vertex and 4 cm anterior to the interaural line, with slight adjustments
for each participant. The optimal position of the coil was then marked
on the scalp with a pen to ensure consistent coil placement throughout
the experiment. The coil was oriented at an angle of 456relative to the
parasagittal plane with the handle pointing posteriorly. This coil ori-
entation induces current flow in a posteroanterior direction in the
underlying cortex.18
MEPs were evoked in the masseter muscle by stimulating the ‘hot
spot’. A light pre-contraction was obtained by asking the participants
to clench their teeth slightly together during TMS. Then, the active
motor threshold (AMT) in the masseter muscle was defined as the
minimum stimulation intensity (at maximum stimulator output) that
could induce MEPs of at least 50 mV in amplitude in 5 out of 10
consecutive trials. The stimulus intensity of rTMS was set at 80% of
the AMT, and the rTMS (1 Hz) was applied for 20 min on one side
with the jaw-closingmuscles at rest (see Figure 1). The same procedure
was then repeated on the contralateral side.
Statistics
A two-way analysis of variance (ANOVA) with repeatedmeasurement
was used to compare EMG events per hour and EMG intensity
amongst the three phases. The NRS scores of the jaw-closing muscle
soreness were analysed by a non-parametric ANOVA. A post hoc
Student–Newman–Keuls test was used for comparison. The mean
values and standard error of the mean (SEM) are presented in the text.
The level of significance was set at 5%.
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RESULTS
A total of 12 patients with probable SB completed the study without
any reports of side effects from rTMS. The hot spot for evoking MEPs
in the masseter muscle could be identified before rTMS was applied
and was located approximately (10.2 6 2.1) cm lateral to the vertex
and (4.56 1.2) cm anterior to the interaural line. The overall AMT for
the right and left massetermuscles was 68.4%6 7.8% and did not vary
across the 5 consecutive days (ANOVA: P 5 0.10). The TMS intensity
used for rTMS was set at 54.7% 6 5.6%.
Jaw-closing muscle activity during sleep
The EMG intensity and the number of EMG bursts per hour at base-
line, during rTMS (during) and after rTMS (post) are shown in
Figure 2a and 2b. The average recording hours during sleep in the
three phases were (5.9 6 1.3), (5.2 6 0.6) and (5.5 6 0.7) h, respec-
tively. There was no significant difference between the recording hours
amongst the phases (P . 0.51).
The two-way ANOVA indicated that there was a significant diffe-
rence in the EMG intensity amongst phases (F 5 7.40, P 5 0.03). Post
hoc tests showed significantly lower EMG intensities during the rTMS
and follow-up phases compared to the baseline (P 5 0.04, P 5 0.02,
respectively; Figure 2a). There were no correlations between days and
sessions (F 5 2.90, P 5 0.13). There were no significant differences
amongst days (F 5 1.44, P 5 0.27).
Regarding the number of EMG bursts, there were no significant
differences amongst days (F 5 0.49, P 5 0.74) or phases (F 5 0.17,
P 5 0.22) and no correlations (F 5 0.90, P 5 0.51) in the number of
EMG events per hour of sleep (Figure 2b).
Jaw-closing muscle soreness
The NRS scores of jaw-closing muscle soreness demonstrated significant
differences amongst phases (P, 0.001). Post hoc tests showed a signifi-
cant decrease in NRS soreness scores during rTMS and the follow-up
phase compared with baseline values (P, 0.001; P, 0.01; Figure 2c).
From the questionnaire data, 6/12 (50%) participants reported less
SB, 2/12 (approximately 17%) reported no change and 4/12 (appro-
ximately 33%) answered ‘do not know’ during rTMS treatment
(phase 2). During the follow-up phase, 5/12 (approximately 42%)
participants still reported less SB, 3/12 (25%) reported no change
and 4/12 (approximately 33%) reported ‘do not know’.
DISCUSSION
In this pilot study with an open and non-controlled design, we applied
the novelmethodology of rTMS in an attempt tomanage patients with
probable SB. Despite the obvious limitations in the study design, we
believe that the present findings, which showed a significant inhibition
of the intensity of jaw-closingmuscle activity during sleep along with a
decrease in patients’ reports of jaw-closing muscle soreness, represent
an important new idea in the understanding of SB and call for further
and more controlled studies.
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Figure 2 Effects of rTMS application. (a) Intensity of EMG activity; (b) numbers
of EMG burst per hour; (c) the NRS scores of jaw-closing muscle soreness
compared amongst baseline, during rTMS (during), and after rTMS (post).
Mean 6 SEM. *indicates significant differences amongst the treatment phases
(P , 0.05). EMG, electromyographic; rTMS, transcranial magnetic stimulation;
SEM, standard error of arithmetic mean.
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10 ms
20-min bilateral
rTMS at 1 Hz, 80% of the AMTb
a
Figure 1 Repetitive transcranial magnetic stimulation rTMS application.
(a) MEPs were evoked in the masseter muscle by stimulating the ‘hot spot’, while
teeth were slightly clenched. The AMTwas detected. (b) The stimulus intensity of
rTMS was set at 80% of the AMT and applied at 1 Hz for 20 min on one side with
the jaw-closing muscles at rest. The same procedure was then repeated on the
contralateral side. AMT, active motor threshold; MEP, motor evoked potential;
rTMS, transcranial magnetic stimulation.
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Effects of rTMS on EMG activity during sleep
TMS is a painless, non-invasive technique that allows investigations of
the motor cortex and descending pathways in humans.19–20 In this
study, we applied low-frequency rTMS (1 Hz) to the face motor cor-
tex, which is the cortical representation of the masseter muscle on the
primarymotor cortex, to trigger transient inhibition of the descending
corticobulbar projections to the trigeminal motor nuclei and brain-
stem reticular formations.21–25 An experimental human study has
found that TMS pulses evoke descending activity in the corticobulbar
axons, subsequently suppressing the excitability of the motoneuron
pool.26 Interestingly, an abnormal excitability in the central mastica-
tory pathway has been suggested in SB patients.27
It is generally accepted that SB is a movement disorder with
increased RMMA related to sleep arousals.28 Transient arousal is an
intermediate state in which the ascending activating systems respons-
ible for waking cortical and cardiac activity are activated but are insuf-
ficient to produce wakefulness. The genesis of RMMA is associated
with a physiological sequence of micro-arousal. Patients with SB may
have an increased responsiveness in their neural circuits that are
responsible for the genesis of rhythmic jaw motor excitation in res-
ponse to micro-arousals.10 Therefore, our data with rTMS of the cor-
tical motor neurons suggest that the rhythmic jaw motor activation
was modified to some extent and had an impact on the patho-
physiology of SB. rTMS treatment may interfere with or block the
neural circuits associated with SB, therefore tending to reduce the
incidence of SB events and lower the intensity of the jaw-closing mus-
cle contractions. A notable finding from the present study was that the
intensity of EMG activity was depressed significantly during rTMS
treatment (Figure 2a) and to a lesser but still significant degree during
the follow-up phase. This suggests a reasonable short-term effect
(within days) of rTMS, but longer treatment periods are needed to
observe more consistent and profound long-term effects on jaw-clos-
ingmuscle activation. It has been reported that rTMS-induced changes
last fromminutes to hours, although some reports have indicated that
synaptic plasticitymay last up toweeks ormonths after the stimulation
period.21,29 Accordingly, it has been suggested that a maintenance
therapy will be needed, which would consist of a priming week or
weeks with daily rTMS sessions followed by maintenance sessions at
longer intervals that could be used to maintain long-lasting effects.30–32
The time course of the inhibitory effects of rTMS on jaw-closingmuscle
activity during sleep will, however, need further studies.
Effects of rTMS on jaw-closing muscle soreness
SB may be associated with muscle symptoms such as pain or soreness.
In this study, we included patients who reported no pain but had
significant levels of jaw-closing muscle soreness, in particular upon
awakening in the morning. rTMS has been applied to manage clinical
pain conditions with variable outcomes.30We therefore decided not to
focus on pain but rather onmuscle soreness in our patient population.
Indeed, rTMS was associated with significant decreases in NRS scores
of jaw-closingmuscle soreness, an effect that persisted in the follow-up
period. In line with the NRS scores, the overall perception of the
treatment effects reported by the patients indicated that rTMS had
significantly improved their muscle symptoms (Figure 2c). A number
of explanations for this observation need to be discussed.
The decrease in NRS scores of jaw-closing muscle soreness could
simply be a placebo effect, i.e., an expectation from the patients that a
new, high-tech technique administered by medical experts would lead
to an improvement in their symptoms. Because the study was not
designed to control for placebo effects or regression towards the mean
(time effects), we cannot completely rule out this possibility. Further-
more, increased cerebral blood flow and increased synaptic neuro-
transmission have also been shown to occur with rTMS, which may
reduce stress chemicals in the brain and thus, have an indirect effect on
muscle soreness and SB.32–33 Nevertheless, the observation that rTMS
also leads to a significant decrease in jaw-closing muscle activity dur-
ing sleep suggests that there could be a physiological effect of rTMS,
although placebo mechanisms may also be mediated during sleep.34 It
could be speculated that rTMS could exert its effect on jaw-closing
muscle soreness through the inhibition of jaw-closing muscle activity
during sleep. The relation between muscle symptoms and muscle
activity during sleep in SB is, however, not linear or straightforward
because several reports have demonstrated that higher levels of jaw-
closing muscle activity during sleep are, perhaps surprisingly, assoc-
iated with fewer reports of muscle symptoms.31,35–36
Methodological concerns
We recognise the limitations of an open and non-controlled study but
would like to note some of the strengths of the present study. First, we
used an objective measure of jaw-closing muscle activity during sleep
over at least five repeated nights, rather than from a single night, to
account for night-to-night variability.37 This allowed a more robust
assessment of the baseline activity and the subsequent treatment
effects during rTMS. It is worth noting that our statistical analyses
used the data from each night but did not find significant differences
across the different nights or correlations between nights and inter-
vention. This suggests that rTMS evoked a pronounced inhibitory
effect on the intensity of the jaw-closing muscle activity during sleep.
The EMG-monitoring device is based on a single channel recording
from the anterior temporalis muscle. Although most studies on SB
have focused on the masseter muscle, there is no indication that the
anterior temporalis should act differently during episodes of SB
because of the high degree of functional overlap and synergistic
actions.
We intended to providemore accurate data about SB than informa-
tion solely based on questionnaires and clinical examinations.38 In the
present study, the ambulatory EMG-recording devices were used at
the subject’s home for extended periods and during multiple nights.
Thus, the EMG recordings did not disturb the natural quality of sleep,
and the recordings could be performed for continuous nights at a
relatively low cost.37
Finally, the present study only included a relatively small study
sample, but the design allowed a within-subject comparison and was
sufficient to detect significant differences between baseline and rTMS
for the intensity of EMG activity andNRS scores of jaw-closingmuscle
soreness. In addition, because of the short-term follow-up design, the
results do not allow speculations about EMG activity in the jaw-
closing muscles at a longer follow-up.
rTMS was carefully applied by only one experienced examiner. The
hot spot was identified in each participant individually on each treat-
ment day. MEP was evoked consistently before the application of
rTMS to secure a specific stimulation of the relevant hot spot, i.e.,
the masseter muscle representation at the primary motor cortex. This
study was not a PSG study, and therefore, we could only identify
probable SB because no gold standard examination technique was
applied. However, the strength was that we could have 5 days of
continuous recordings during each of the three phases, which may
not have been feasible with PSG recordings. Importantly, the present
ambulatory EMG technique will be less influenced by night-to-night
variations.
TMS on bruxism
WN Zhou et al
International Journal of Oral Science
64
CONCLUSIONS
This pilot study raises the possibility that the novel application of
rTMS in patients with SB could have beneficial effects. Controlled
and long-term studies with larger sample sizes are needed to replicate
the findings.
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